
NeuLogiq platform proves effective for at-home ALS and FTD monitoring
A study published in Scientific Reports validates the feasibility of using the NeuLogiq platform to perform multimodal cognitive assessments at home for patients with ALS and FTD. The research reveals that individuals with significant motor and cognitive impairment can successfully manage remote EEG and gamified testing protocols.




.jpeg)





















